The recent decision by the Health Service Executive (HSE) to scrap the insourcing initiative has sparked concern among healthcare professionals and patients alike. This move, which aims to improve access to healthcare, could potentially lead to a significant increase in waiting lists, with estimates ranging from 2,000 to 4,000 additional patients per month. The insourcing initiative, which involved private companies using HSE staff and equipment after hours to treat patients on waiting lists, has been a critical enabler of service delivery across the region. It accounted for a substantial portion of new outpatient activity and endoscopy capacity, playing a pivotal role in managing waiting lists and meeting targets. However, the HSE's decision to abolish the initiative has raised questions about the potential consequences for patients and the healthcare system.
The internal report, sent to HSE leadership, highlights the risks associated with the abrupt ending of insourcing. It warns of a rapid growth in waiting lists, a loss of momentum, and an increased reliance on outsourcing at potentially higher costs. The report also emphasizes the risk of widening existing inequities in access, particularly in rural and peripheral areas. This is a critical issue, as the HSE region has already faced challenges in providing equitable access to healthcare.
One of the key concerns is the impact on patients who have been referred by a GP to see a hospital consultant. The outpatient waiting list, which is a queue for these patients, could experience a significant increase in numbers. This could lead to longer wait times and potentially more patients breaching urgent targets, such as those for colonoscopy and breast assessments. The report proposes a regionally tailored approach to cessation, suggesting five options to mitigate the risks. These options include permitting the region to continue its use of third-party insourcing, introducing regional flexibility, and maintaining insourcing for high-demand specialities and long waiters.
The HSE's response to the report is also noteworthy. A spokeswoman acknowledged the concerns and mentioned that a range of measures are being progressed to support regions, including service developments, capacity measures, planned overtime, and the use of appropriate outsourcing arrangements. However, the HSE West and North West region has expressed its disagreement with the report's findings, arguing that it did not consider alternatives to managing waiting lists. This disagreement highlights the complexity of the issue and the need for a comprehensive approach to finding solutions.
In my opinion, the HSE's decision to scrap the insourcing initiative without a well-thought-out plan for alternatives is a cause for concern. While the initiative has been successful in improving access to healthcare, the potential consequences for patients and the healthcare system cannot be ignored. The HSE must carefully consider the risks and explore all possible options to ensure that patient care is not compromised. This includes investing in alternative solutions that can provide similar benefits without the same risks. The future of healthcare delivery in the region hangs in the balance, and the HSE must act swiftly and decisively to address these concerns.
